Sartorius earns silver in EcoVadis CSR rating
The company’s engagement in Corporate Social Responsibility includes reducing consumption of water in manufacturing by using innovative technologies.
Sartorius has been awarded for its responsible activities in the areas of environment, labour practices, ethics and sustainable procurement. The company’s engagement in Corporate Social Responsibility (CSR) ranges from supporting the United Nations Global Compact to reducing consumption of water in manufacturing by using innovative technologies, for example, to holding comprehensive employee training courses on work safety. By earning the silver recognition level in the EcoVadis CSR rating platform, Sartorius has positioned itself among the best 30% of the companies assessed.
Companies are increasingly expected to take responsibility not only for their own business activities but also for sustainable supply chain management. EcoVadis operates a platform that provides CSR ratings for global supply chains. The methodology EcoVadis uses in its assessment is based on international CSR standards, such as the international Global Reporting Initiative, the United Nations Global Compact and the ISO 26000 Standard providing guidance on social responsibility. The analytical system covers 21 sustainability criteria for the environment, social aspects, ethics and sustainable procurement. More than 45,000 companies in over 150 countries use EcoVadis. The objective is to create transparency and trust in customer-supplier relationships. EcoVadis assessment is also designed to help drive continuous improvement and minimize the risks of non-compliance with labour and environmental standards.
Sustainability is gaining growing importance worldwide. Customers and investors are increasingly interested in receiving information on environmental practices, business ethics and corporate governance. The silver recognition level confirms the importance that Sartorius attaches to long-term-focused, responsible activities with regard to natural resources, as well as to business partners and staff. As Sartorius moved up in its ranking from bronze to silver, this underlines the company’s progress in the area of CSR.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance